Thymosin Alpha 1 (TA-1) 5MG Research Vial - Third-Party Tested

Thymosin Alpha 1 Research That Actually Gets Used

Most research peptide vendors ask you to take their word for quality. No batch documentation, no named testing facility, no transparent process for how the product was made or verified. You're ordering blind and hoping the compound you receive is what the label says it is.

Helio Peptides was built on a different premise entirely.

Every vial of Thymosin Alpha 1 goes through independent third-party testing at an ISO 17025-accredited laboratory before it leaves our US facility - confirming identity by HPLC, verifying molecular weight by mass spectrometry, and confirming the assay content matches the labelled 5MG. The Certificate of Analysis is available on request. Not buried, not theoretical - available.

That's the foundation. Here's the product.

What Makes This Vial Different

The research peptide market has no shortage of TA-1 suppliers. What's rare is a supplier who can demonstrate quality rather than simply claim it. Here's what separates the Helio Peptides Thymosin Alpha 1 5MG vial:

Third-party tested at an ISO 17025-accredited lab. This is the meaningful distinction. ISO 17025 is the international standard for testing laboratory competence - it means the lab doing the testing has itself been independently verified for technical accuracy and measurement reliability. Every Helio Peptides TA-1 batch comes with HPLC and mass spectrometry data from such a facility.

USA manufactured. Synthesised by solid-phase peptide synthesis (SPPS) in a controlled US-based facility under strict manufacturing standards. Not imported, not repackaged, not relabelled - manufactured here, tested here, shipped from here.

Sequence-identical to endogenous Thymosin Alpha 1. The 28-amino acid acetylated sequence - Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH - confirmed by MS at every batch.

Stable lyophilised format. A lyophilised vial is stable at room temperature for moderate-term storage, ships cold-chain, and doesn't require refrigeration during transit. Unlike liquid peptide products, there's no risk of degradation during shipping - your compound arrives in the same condition it left our facility.

Transparent pricing with a bulk option. Single vial at $59.95. Pack of ten at $53.96 per vial - a 10% saving for labs or research programs maintaining consistent supply. No hidden fees, no forced subscriptions.

What Is Thymosin Alpha 1 (TA-1)?

Thymosin Alpha 1 - abbreviated as TA-1 or Tα1 and also known pharmaceutically as thymalfasin - is a naturally occurring 28-amino acid peptide first isolated from thymosin fraction 5 of bovine thymic tissue in the early 1970s. It represents the biologically active N-terminal fragment of Prothymosin Alpha, a larger precursor protein expressed primarily in thymic epithelial cells.

Its sustained presence in biomedical research literature stems from a well-characterised role in T-lymphocyte maturation and immune signalling. In physiological conditions, Thymosin Alpha 1 contributes to the differentiation of naive T-cells within the thymus - a process fundamental to the development of adaptive immunity. Its amino acid sequence is fully conserved across mammalian species, a property that has made it particularly useful in cross-species comparative immunology research.

The synthetic form used in laboratory research - including the compound in this vial - is produced via solid-phase peptide synthesis (SPPS) and is sequence-identical to the naturally occurring human peptide. Supplied in lyophilised powder form, it offers significantly greater stability than aqueous solutions and is the standard presentation for research-grade TA-1 worldwide.

Thymosin Alpha 1 is a distinct compound from Thymosin Beta 4 - the peptide available as the TB-500 5MG Vial. Despite sharing the 'thymosin' naming convention, the two peptides have entirely different amino acid sequences, separate mechanisms of action, and distinct research profiles. TA-1 research is centred on immune modulation; TB-500 research is primarily focused on tissue repair and regeneration models.

"The level of documentation Helio Peptides provides - COA on request, named accredited lab, HPLC and MS confirmation - is what you need when your research depends on compound identity. This is the standard, not a bonus." - Research community feedback on transparent COA practices

Research Applications

Thymosin Alpha 1 is one of the most extensively characterised immunomodulatory peptides in the scientific literature. The following areas represent documented research directions from peer-reviewed studies. All work must be conducted in controlled laboratory environments in compliance with applicable regulations. This product is for research use only and is not for human or animal consumption.

Immune System Modulation

The most thoroughly documented research area for TA-1 is its capacity to modulate innate and adaptive immune function. Preclinical studies have demonstrated that Thymosin Alpha 1 can upregulate MHC class II antigen expression on T-lymphocytes, promote the differentiation of naive T-helper cells into functional CD4+ subsets, and enhance natural killer (NK) cell cytotoxicity. These effects are understood to occur through interaction with toll-like receptors TLR-7 and TLR-9 - pattern recognition receptors in the innate immune system that detect viral nucleic acids and trigger downstream inflammatory and antiviral signalling cascades.

Research examining TA-1 in immunosuppressed model systems has focused on restoration of T-cell competence as a primary endpoint - an area of relevance in cancer immunology, post-infectious immune recovery, and chronic inflammatory disease models. Thymosin Alpha 1's well-characterised mechanism and decades-long research history make it a valuable reference compound for laboratories investigating immune pathway modulation in vitro and in vivo.

Antiviral Research

Thymosin Alpha 1 has accumulated a substantial research record in antiviral model systems. Early investigations examined TA-1 in Hepatitis B and Hepatitis C models, where its ability to enhance interferon-gamma production and stimulate cytotoxic T-lymphocyte responses made it a compound of interest in chronic viral infection research. More recent peer-reviewed work has examined TA-1 in influenza, HIV, and SARS-CoV-2 model contexts, where its TLR-7 and TLR-9 agonist activity has been explored as a mechanism for augmenting innate antiviral responses.

Antimicrobial research has also explored TA-1 in bacterial infection models - including studies examining sepsis-associated immune dysregulation, where its capacity to reduce immunoparalysis has been a focus of mechanistic investigation.

Oncological Immunology

The intersection of Thymosin Alpha 1 and oncological immunology represents a current and active research direction. Studies have investigated TA-1's effects on dendritic cell maturation and antigen presentation capacity, NK cell cytotoxicity against tumour cell lines, and modulation of regulatory T-cell (Treg) populations associated with immune evasion in tumour microenvironments.

Combination research - examining TA-1 alongside checkpoint inhibitor analogues, cytokine pathway modulators, and other immunostimulatory agents - represents a growing area of interest for laboratories studying immune-oncology mechanisms.

Product Specifications

Purity Testing & Certificate of Analysis

Every batch of Helio Peptides Thymosin Alpha 1 is independently analysed before release. Not sampled - every batch. Testing is conducted by an ISO 17025-accredited third-party laboratory using two separate analytical methods:

• HPLC (High-Performance Liquid Chromatography): Separates the peptide against certified reference standards to confirm identity, detect synthesis by-products, and quantify purity

• Mass Spectrometry (MS): Determines the exact molecular mass, providing unambiguous sequence confirmation - ruling out errors, substitutions, or truncated synthesis products

• Assay / Content Testing: Confirms the exact quantity of active peptide per vial matches the labelled 5MG

The COA for any specific batch is available on request. Email info@heliopeptides.com with your order number and batch details, or use the live chat on site. The COA includes batch number, testing date, facility credentials, HPLC chromatogram, MS data, and final assay result.

For a full explanation of our testing methodology and how to read a COA, visit the Certificate of Analysis and Testing page.

How to Reconstitute Thymosin Alpha 1

Thymosin Alpha 1 is supplied as a lyophilised powder and must be reconstituted with a sterile diluent before laboratory use. Doing it correctly ensures a stable, accurately concentrated solution.

1. Allow the vial to reach room temperature before opening - prevents moisture condensation on the powder

2. Draw the required volume of bacteriostatic water (BW) or sterile water for injection (SWFI) using a sterile needle and syringe

3. Inject the diluent slowly along the inner wall of the vial - not directly onto the powder

4. Gently swirl in a circular motion until fully dissolved - do not shake or vortex

5. Inspect the solution - it should be clear and colourless. Discard if cloudiness or particles are visible

6. Store reconstituted solution at 4°C and use within 2–4 weeks, or aliquot and freeze at -80°C

Bacteriostatic water is the preferred diluent - its 0.9% benzyl alcohol content inhibits microbial growth and extends the stable use window of the reconstituted solution. Sterile water is acceptable for single-use applications. Avoid acidic or alkaline diluents.

For a full guide to reconstitution and laboratory handling protocols, visit the Helio Peptides FAQ page.

Storage Guidelines

Peptide degradation from incorrect storage is the most common source of variability in research results - and it's entirely preventable.

• On delivery: store immediately - do not leave at room temperature for extended periods

• Short-term (days to weeks): refrigerate at 4°C, away from direct light, in original or opaque packaging

• Long-term (months to years): freeze at -80°C - maximises stability and minimises degradation

• Avoid repeated freeze-thaw cycles: aliquot before freezing if the vial will be used across multiple sessions

• Reconstituted solution: 4°C for up to 2–4 weeks, or -80°C in aliquots for longer storage

Helio Peptides ships all vials with cold-chain packaging. If you have any concerns about vial condition on arrival, contact info@heliopeptides.com or call 1-855-435-4633 immediately.

The Dosing Breakdown

Researchers maintaining regular supply for ongoing studies will find the pack of 10 provides the best combination of cost efficiency and batch consistency. Each vial in a pack comes from the same production batch where possible, reducing inter-batch variability across a research programme.

How Thymosin Alpha 1 Fits the Helio Lineup

Different peptides serve different research contexts. For many programmes, multiple compounds are used in parallel or sequence:

When to choose Thymosin Alpha 1: Your research involves immune pathway modulation, T-cell differentiation, antiviral signalling, or immunological response characterisation. TA-1 is the primary choice for any investigation centred on adaptive or innate immune mechanisms.

When to also consider TB-500: If your research involves parallel tissue repair models alongside immune function studies, the TB-500 5MG Vial is the companion compound. Both are thymic peptides - entirely different mechanisms, often co-investigated in regenerative immunology research.

When to also consider BPC-157: For research programmes combining systemic repair models with immune modulation, BPC-157 Vial is among the most frequently co-researched peptides with TA-1 in the published literature.

When to also consider Epithalon: Researchers investigating longevity pathways, telomere biology, or bioregulator mechanisms alongside immune function will find the Epithalon 10MG Vial a natural companion compound to TA-1.

When to also consider GHK-Cu: Studies examining the intersection of immune signalling and tissue regeneration often incorporate the GHK-Cu 50MG Vial alongside TA-1 as a copper peptide reference compound.

Shipping & Fulfilment

Frequently Asked Questions

What is Thymosin Alpha 1 used for in research? TA-1 is studied in controlled laboratory settings for immune system modulation, T-cell differentiation, antiviral signalling through TLR-7/TLR-9 pathways, and oncological immunology. Research use only - not for human or animal consumption.

Is Thymosin Alpha 1 the same as Zadaxin? Zadaxin is a pharmaceutical brand name for synthetic thymalfasin used clinically in certain countries. The Helio Peptides vial is a research-grade compound for laboratory use only - not a pharmaceutical product and not intended for diagnostic or therapeutic purposes.

What is the molecular weight of Thymosin Alpha 1? 3,108.3 g/mol. Molecular formula C₁₂₉H₂₁₅N₃₃O₅₅. CAS number 62304-98-7. 28-amino acid acetylated peptide, sequence-identical to the endogenous human form.

How is Thymosin Alpha 1 different from TB-500? Despite both being thymic peptides, TA-1 and TB-500 are completely different compounds. TA-1 is a 28-amino acid immunomodulatory peptide studied in immune and antiviral research. TB-500 is studied primarily in tissue repair and regeneration models. Both are available as separate vials from Helio Peptides.

How do I reconstitute Thymosin Alpha 1? Add bacteriostatic water or sterile water slowly along the inner vial wall. Gently swirl until dissolved - do not shake. All procedures must follow your institution's laboratory handling protocols.

How should I store Thymosin Alpha 1? Short-term: 4°C. Long-term: -80°C. Keep away from light. Avoid repeated freeze-thaw cycles. Reconstituted solution: use within 2–4 weeks at 4°C, or freeze aliquots at -80°C.

Is every batch third-party tested? Yes. Every batch - not every product line, every batch - is tested by an ISO 17025-accredited laboratory using HPLC and mass spectrometry. COA available on request at info@heliopeptides.com.

Where is Helio Peptides Thymosin Alpha 1 manufactured? Synthesised in the United States by solid-phase peptide synthesis (SPPS) in a controlled US-based facility. USA made, USA tested, shipped same day from the US.

Does Helio Peptides ship internationally? Contact info@heliopeptides.com  or call 1-855-435-4633 for current international shipping availability. Domestic US orders receive same-day dispatch with 1–3 business day delivery.

What payment methods are accepted? Credit/debit card (3D Secure), bank transfer, and cryptocurrency - Ethereum (ETH), Bitcoin (BTC), and USDC at locked exchange rates.

Is Thymosin Alpha 1 legal to buy in the USA? Thymosin Alpha 1 is sold as a research chemical for laboratory use only. It is not a scheduled controlled substance in the United States and is not FDA-approved for human use. All purchases must comply with applicable federal and state laws. Buyers confirm research intent at checkout.

What does a Certificate of Analysis include? The COA includes batch number, testing date, ISO 17025 facility credentials, HPLC chromatogram, MS data, and final assay result confirming the labelled 5MG quantity. Available on request - email info@heliopeptides.com  with your order number.

Is there a bulk discount on Thymosin Alpha 1? Yes. A pack of 10 vials is priced at $53.96 per vial - a 10% saving over the single-vial price of $59.95. For larger institutional or wholesale enquiries, contact info@heliopeptides.com .

How does TA-1 interact with toll-like receptors? Research indicates TA-1 activates TLR-7 and TLR-9 - innate immune pattern recognition receptors that detect viral RNA and unmethylated CpG DNA. This mechanism is central to TA-1's role in antiviral and immunostimulatory research. See PubMed CAS 62304-98-7 for published references.

How is Thymosin Alpha 1 different from BPC-157? Unrelated peptides - different sequences, different mechanisms, different research profiles. TA-1 focuses on immune modulation. BPC-157 is studied in gastrointestinal, tendon, and systemic repair models. Both are available from Helio Peptides with full COA documentation.

Explore More From Helio Peptides

• TB-500 5MG Vial - tissue repair and regeneration research

• BPC-157 Vial - GI tract, tendon, and systemic repair research

• Epithalon 10MG Vial - longevity and bioregulator research

• GHK-Cu 50MG Vial - copper peptide, collagen, and immune signalling research

• KPV 10MG Vial - anti-inflammatory tripeptide, gut and immune research

• MOTS-c 10MG Vial - mitochondrial peptide, metabolic research

• Wholesale & Bulk Orders - institutional pricing for research programmes

All products sold on heliopeptides.com are intended solely for laboratory research and are not for human or animal consumption. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the buyer confirms they are a qualified researcher and agrees to comply with all applicable federal and state laws. Not for sale to persons under the age of 21.